Pharma Mar Valuation
| PHMMF Stock | USD 88.72 1.84 2.03% |
At this time, the company appears to be fairly valued. Pharma Mar SAU holds a recent Real Value of $88.95 per share. The prevailing price of the company is $88.72. Our model determines the value of Pharma Mar SAU from analyzing the company fundamentals such as Return On Equity of 0.47, operating margin of 0.33 %, and Shares Outstanding of 18.09 M as well as examining its technical indicators and probability of bankruptcy.
Fairly Valued
Today
Please note that Pharma Mar's price fluctuation is very steady at this time. Calculation of the real value of Pharma Mar SAU is based on 3 months time horizon. Increasing Pharma Mar's time horizon generally increases the accuracy of value calculation and significantly improves the predictive power of the methodology used.
The fair value of the Pharma pink sheet is determined by what a typical buyer is willing to pay for full or partial control of Pharma Mar SAU. Since Pharma Mar is currently traded on the exchange, buyers and sellers on that exchange determine the market value of Pharma Pink Sheet. However, Pharma Mar's intrinsic value may or may not be the same as its current market price, in which case there is an opportunity to profit from the mispricing, assuming the market price will eventually merge with its intrinsic value. | Historical | Market 88.72 | Real 88.95 | Hype 88.72 |
The real value of Pharma Pink Sheet, also known as its intrinsic value, is the underlying worth of Pharma Mar SAU Company, which is reflected in its stock price. It is based on Pharma Mar's financial performance, growth prospects, management team, or industry conditions. The intrinsic value of Pharma Mar's stock can be calculated using various methods such as discounted cash flow analysis, price-to-earnings ratio, or price-to-book ratio. That value may differ from its current market price, which is determined by supply and demand factors such as investor sentiment, market trends, or news.
Estimating the potential upside or downside of Pharma Mar SAU helps investors to forecast how Pharma pink sheet's addition to their portfolios will impact the overall performance. We also use other valuation drivers to help us estimate the true value of Pharma Mar more accurately as focusing exclusively on Pharma Mar's fundamentals will not take into account other important factors: About Pharma Mar Valuation
The pink sheet valuation mechanism determines Pharma Mar's current worth on a weekly basis. Our valuation model uses a comparative analysis of Pharma Mar. We calculate exposure to Pharma Mar's market risk, different technical and fundamental indicators, and relevant financial multiples and ratios and then compare them to those of Pharma Mar's related companies.Pharma Mar, S.A., a biopharmaceutical company, engages in the research, development, production, and commercialization of bio-active principles of marine origin for use in oncology in Spain, Italy, Germany, Ireland, rest of EU, the United States, and internationally. The company was incorporated in 1986 and is based in Madrid, Spain. Pharma Mar operates under Biotechnology classification in the United States and is traded on OTC Exchange. It employs 477 people.
8 Steps to conduct Pharma Mar's Valuation Analysis
Company's valuation is the process of determining the worth of any company in monetary terms. It estimates Pharma Mar's potential worth based on factors such as financial performance, market conditions, growth prospects, and overall economic environment. The result of company valuation is a single number representing a Company's current market value. This value can be used as a benchmark for various financial transactions such as mergers and acquisitions, initial public offerings (IPOs), or private equity investments. To conduct Pharma Mar's valuation analysis, follow these 8 steps:- Gather financial information: Obtain Pharma Mar's financial statements, including balance sheets, income statements, and cash flow statements.
- Determine Pharma Mar's revenue streams: Identify Pharma Mar's primary sources of revenue, including products or services offered, target markets, and pricing strategies.
- Analyze market data: Research Pharma Mar's industry and market trends, including the size of the market, growth rate, and competition.
- Establish Pharma Mar's growth potential: Evaluate Pharma Mar's management, business model, and growth potential.
- Determine Pharma Mar's financial performance: Analyze its financial statements to assess its historical performance and future potential.
- Choose a valuation method: Consider the Company's specific circumstances and choose an appropriate valuation method, such as the discounted cash flow (DCF) or comparable analysis method.
- Calculate the value: Apply the chosen valuation method to the financial information and market data to calculate Pharma Mar's estimated value.
- Review and adjust: Review the results and make necessary adjustments, considering any relevant factors that may have been missed or overlooked.
Pharma Mar Growth Indicators
Investing in growth stocks can be very risky. If the company such as Pharma Mar does not do well, investors take a loss on the stock when it is time to sell. Also, because growth stocks typically do not pay dividends, the only opportunity an investor has to make money on their investment is when they eventually sell their shares.
| Common Stock Shares Outstanding | 18 M | |
| Quarterly Earnings Growth Y O Y | 5.215 | |
| Retained Earnings | 121.3 M |
Complementary Tools for Pharma Pink Sheet analysis
When running Pharma Mar's price analysis, check to measure Pharma Mar's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Pharma Mar is operating at the current time. Most of Pharma Mar's value examination focuses on studying past and present price action to predict the probability of Pharma Mar's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Pharma Mar's price. Additionally, you may evaluate how the addition of Pharma Mar to your portfolios can decrease your overall portfolio volatility.
| Portfolio Anywhere Track or share privately all of your investments from the convenience of any device | |
| Equity Valuation Check real value of public entities based on technical and fundamental data | |
| Equity Analysis Research over 250,000 global equities including funds, stocks and ETFs to find investment opportunities | |
| Share Portfolio Track or share privately all of your investments from the convenience of any device |